Sanofi bispecific sees respiratory ph. 2 wins, eczema fail
Sanofi’s TSLP and IL-13 inhibitor has aced a pair of mid-stage studies for respiratory diseases, but missed on…
Press Release: Sanofi’s lunsekimig met primary and key
Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP The AIRCULES phase…
Kinston girl survives near-fatal asthma attack with help from Greenville’s Maynard Children’s Hospital
GREENVILLE, N.C. (WITN) – Fendi Perry is like any other seven-year-old. She likes riding on her scooter and…